Italy Asthma Inhaler Device Market
Italy Asthma Inhaler Device Market Research Report: By Type (Metered Dose Inhalers, Dry Powder Inhalers, Soft Mist Inhalers), By Mode of Operation (Manually Operated Inhaler Devices, Digitally-Operated Inhaler Devices) andBy End User (Hospitals & Clinics, Homecare)- Forecast to 2035
Industry Developments
The Italy Asthma Inhaler Device Market has witnessed significant developments in recent months. Notable companies such as Pfizer, AbbVie, and GlaxoSmithKline are actively engaging in advancements in their asthma inhaler technologies. For instance, Chiesi Farmaceutici announced in August 2023 its ongoing efforts in developing advanced inhalation therapies aimed at improving patient compliance and medication adherence. Additionally, Boehringer Ingelheim has been focusing on research and development projects to enhance drug delivery systems to meet the specific needs of Italian patients. In recent merger and acquisition news, AstraZeneca and Merck & Co finalized their strategic agreement in September 2023 to jointly promote certain respiratory inhalation products across Italy, showcasing a trend of collaboration aimed at innovation in asthma therapies. Over the past few years, Italy has seen a growth in the valuation of asthma inhaler devices, driven by government investments in healthcare technology and rising awareness of respiratory diseases. Furthermore, changes in regulations in 2021 have encouraged better access to new inhaler technologies for patients across the country, impacting market dynamics significantly.
Report Scope
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2018 | 47.04(USD Million) |
| MARKET SIZE 2024 | 51.74(USD Million) |
| MARKET SIZE 2035 | 114.0(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 7.445% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Million |
| KEY COMPANIES PROFILED | Pfizer, AbbVie, GlaxoSmithKline, Roche, Boehringer Ingelheim, Chiesi Farmaceutici, BristolMyers Squibb, Mylan, Novartis, Sanofi, HoffmannLa Roche, Otonomy, Teva Pharmaceutical Industries, AstraZeneca, Merck & Co |
| SEGMENTS COVERED | Type, Mode of Operation, End User |
| KEY MARKET OPPORTUNITIES | Increasing prevalence of asthma, Adoption of smart inhalers, Growth in home healthcare, Enhanced availability of telemedicine, Rising aging population with respiratory issues |
| KEY MARKET DYNAMICS | rising asthma prevalence, growing healthcare awareness, technological advancements in devices, increasing focus on patient compliance, expansion of insurance coverage |
| COUNTRIES COVERED | Italy |
FAQs
What is the expected market size of the Italy Asthma Inhaler Device Market in 2024?
The market size of the Italy Asthma Inhaler Device Market is expected to be valued at 51.74 million USD in 2024.
What is the projected market size for the Italy Asthma Inhaler Device Market by 2035?
By 2035, the Italy Asthma Inhaler Device Market is projected to reach a value of 114.0 million USD.
What is the expected compound annual growth rate (CAGR) for the Italy Asthma Inhaler Device Market from 2025 to 2035?
The expected CAGR for the Italy Asthma Inhaler Device Market from 2025 to 2035 is 7.445%.
Which type of inhaler is expected to have the largest market share in 2024?
In 2024, the Metered Dose Inhalers segment is expected to have the largest market share, valued at 20.52 million USD.
What is the expected market size for Dry Powder Inhalers in 2035?
The market size for Dry Powder Inhalers is expected to be 37.68 million USD by 2035.
Who are the major players in the Italy Asthma Inhaler Device Market?
Major players in the market include companies such as Pfizer, AbbVie, GlaxoSmithKline, and Roche.
What opportunities and trends are shaping the Italy Asthma Inhaler Device Market?
Key opportunities include advancements in inhaler technology and increasing awareness about asthma management.
What is the anticipated market growth rate for the Metered Dose Inhalers segment from 2025 to 2035?
The Metered Dose Inhalers segment is expected to show significant growth, reaching 45.76 million USD by 2035.
How much is the Soft Mist Inhalers segment expected to be valued in 2035?
The Soft Mist Inhalers segment is expected to be valued at 30.56 million USD by 2035.
What factors are driving the growth of the Italy Asthma Inhaler Device Market?
Growth drivers include the increasing prevalence of asthma and greater product innovations in inhaler design.
Kindly complete the form below to receive a free sample of this Report
Customer Stories
“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”
“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”
“Thanks for sending the report it gives us a good global view of the Betaïne market.”
“Thank you, this will be very helpful for OQS.”
“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”
“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”
“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”
“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”